
Swiss multinational Cotecna has acquired Energon Labs, an analytical testing laboratory based in Hyderabad, the company announced on Saturday, 17 October. The Deccan Chronicle reports Energon is cGMP-compliant, USFDA-inspected, and certified under ISO 9001:2015 and ISO 17025:2017. The financial terms of the deal were not disclosed.
The acquisition strengthens Cotecna's global Life Sciences platform and expands its pharmaceutical testing capabilities across pharmaceutical, biopharmaceutical, medical device and packaging sectors, The Hindu reports. Energon, which serves customers across India, the U.S., Asia-Pacific and the Middle East, will complement Cotecna's existing network that includes Cotecna Life Sciences, Shiva Analyticals and Neotron Pharma.
Cotecna CEO Sebastien Dannaud said the acquisition supports the company's ambition to become one of the largest Life Sciences testing services providers in India. Energon founder Manikanth Reddy said joining Cotecna opens a new chapter for the lab.
Both outlets present the acquisition as a straightforward business announcement with no critical or political framing. The Hindu leads with Cotecna's global strategy and the CEO's ambition, while the Deccan Chronicle adds more operational detail about Energon's certifications and service portfolio. The Deccan Chronicle also includes direct quotes from Cotecna's South Asia CEO Amit Chopra and founder Manikanth Reddy, giving the story a local ecosystem angle. The coverage is uniform straight reporting, neither outlet questions the deal or its implications. The next step is integration of Energon into Cotecna's network.
Coverage: 2 sources, 2 neutral
Sources (2): thehindu.com (neutral report), deccanchronicle.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.